Biotech Sector

Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
Is Novavax Finally Turning Things Around?
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
Is Novavax Finally Turning Things Around?
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

Biotech Sector Recent News

The Week Ahead In Biotech: J&J Earnings Kickstarts Pharma Earnings, More IPOs In The Pipeline
Biotech stocks advanced along with the broader market in the week ended Oct. 9, although the news flow was quite light.
The Week Ahead In Biotech: Avenue's FDA Decision, Alkermes Adcom Meeting, Aziyo Biologics IPO
Biotech stocks made a steady recovery over the week ended Oct. 2, although Friday's weakness trimmed some of the gains of the week.
The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix
Biotech stocks found themselves among gains in the week ended Sept. 18, with conference presentations, IPO news flow and updates on coronavirus vaccine/antibody candidates catalyzing some strong moves.
Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine
Novavax Inc. (NASDAQ: NVAX) announced on Monday it had started the first phase of its novel coronavirus (COVID-19) vaccine trials.
Moderna To Raise $1.3B In A Public Offering As Coronavirus Vaccine Trials See Progress
Moderna Inc. (NASDAQ: MRNA) announced Monday it is planning to raise more than $1.3 billion in a secondary public offering.
Osmotica's IPO: What You Need To Know
From A(erie) To Z(ynerba): Biotech Catalysts Lined Up For Second Half Of 2017
This Biotech Name May Be A Clear Best In Breed For 2017
Big Short Interest On These 5 Biotech Stocks
Why Gilead Sciences, Inc. Is A Top Mutual Fund Holding
4 Ebola Researching Biotech Companies For Your Portfolio
BioMarin Weathers The Storm
4 ETFs With Upside Potential
Biogen Raises Full-Year Earnings, But Is That The Entire Picture?
Biotech ETFs Come Back Down To Earth
Amarin's Vascepa: Too Limited A Market Or FDA Blunder?
Small-Cap Corner: A Forgotten Biotech ETF
NASDAQ Biotech Market Gainers; (BPAX), (CELG), (GILD) Stocks to Watch
Big Meeting Could Mean Big Gains For Biotech Investors
Mid Cap Biotechs May Outperform In 2010